Skip to main navigation Skip to search Skip to main content

Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)1680-1693
Number of pages14
JournalInternational Journal of Cancer
Volume147
Issue number6
DOIs
Publication statusPublished - 2 Mar 2020

Funding

We are indebted to Mira Stojanovic, Irene Herbacek and Gerhard Zeitler for competent technical assistance. This project was supported by the Austrian Science Fund (FWF; P30105 and P19920 to W.B., I4164 to J.G., P28853 to C.R.K) and by Herzfelder'sche Familienstiftung (to C.P.).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 301904 Cancer research
  • 104002 Analytical chemistry
  • 301206 Pharmacology

Keywords

  • Ponatinib
  • lipid droplets
  • resistance
  • cancer
  • drug sequestration
  • BREAST-CANCER CELLS
  • ACCUMULATION
  • ROLES

Fingerprint

Dive into the research topics of 'Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib'. Together they form a unique fingerprint.

Cite this